This website uses cookies to enhance the user experience.
21st logo
||
CR

Christian Renskoug Ole1947

Shareholdings
23
Arrow
0
Double arrow
Norway Business roles
0

Roles

No available data

Related industries

No related industries

Direct relationships

No direct relationships

Shares owned by Christian Renskoug Ole

NameShare classTotal operating incomeTotal equityShare
S
SOLSKJERMING AS
Ordinære aksjer
11,522,577
3,052,841
20 %
directly
O
OBSERVE MEDICAL ASA
Ordinære aksjer
2,935,000
12,296,000
0.03 %
directly < 0.01 %
D
DESERT CONTROL AS
Ordinære aksjer
149,000
162,116,000
0.02 %
directly < 0.01 %
A
AKER ASA
Ordinære aksjer
0
18,422,000,000
< 0.01 %
directly
A
ATLANTIC SAPPHIRE ASA
Ordinære aksjer
13,937,000
2,072,487,000
< 0.01 %
directly
E
ELKEM ASA
Ordinære aksjer
8,461,000,000
0
< 0.01 %
directly
E
ELEKTROIMPORTØREN AS
Ordinære aksjer
0
523,469,775
< 0.01 %
directly
V
VÅR ENERGI ASA
Ordinære aksjer
8,096,000,000
560,000,000
< 0.01 %
directly
A
AXACTOR ASA
Ordinære aksjer
258,393,000
367,758,000
< 0.01 %
directly
S
SCANA ASA
Ordinære aksjer
24,000,000
886,000,000
< 0.01 %
directly
N
NEKKAR ASA
Ordinære aksjer
6,938,000
412,133,000
< 0.01 %
directly
H
HEXAGON COMPOSITES ASA
Ordinære aksjer
101,576,000
2,520,134,000
< 0.01 %
directly
K
KITRON ASA
Ordinære aksjer
258,812,000
2,084,995,000
< 0.01 %
directly
I
IDEX BIOMETRICS ASA
Ordinære aksjer
256,000
4,020,000
< 0.01 %
directly
R
REC SILICON HOLDINGS AS
Ordinære aksjer
0
16,124,000
< 0.01 %
directly
D
DELTAGER AS
Ordinære aksjer
21,795,361
0
< 0.01 %
directly
N
NEXT BIOMETRICS GROUP ASA
Ordinære aksjer
6,616,000
219,899,000
< 0.01 %
directly
A
AKASTOR ASA
Ordinære aksjer
5,000,000
4,793,000,000
< 0.01 %
directly
N
NYKODE THERAPEUTICS ASA
Ordinære aksjer
453,000
94,977,000
< 0.01 %
directly
O
ONCOINVENT ASA
Ordinære aksjer
1,909,000
122,658,000
< 0.01 %
directly
P
PANORO ENERGY ASA
Ordinære aksjer
0
123,379,000
< 0.01 %
directly
T
THOR MEDICAL ASA
Ordinære aksjer
839,000
475,867,000
< 0.01 %
directly
V
VOW ASA
Ordinære aksjer
0
684,000,000
< 0.01 %
directly

Limited to direct ownership positions of 0.5% or more.

Last update: Sep 25, 2026